1 active not recruiting, 1 not yet recruiting, 1 recruiting. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 1 | Active not recruiting 1 |
Follow pyrvinium: new trials by email Literature Review of pyrvinium trials Research Report on pyrvinium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Pyrvinium to Reverse Stomach Precancerous Conditions Placebo, Pyrvinium, Blood biomarkers analyses - STOMACH NEOPLASM | Phase 2 | Not yet recruiting | National University Hospital, Singapore | 50 | 2026-11-01 | 2026-10-13 |
| REVerse Intestinal Metaplasia in the Stomach (REVISE) Pyrvinium, Placebo - Gastric Intestinal Metaplasia, Gastric Precancer | Phase 2 | Recruiting | Katherine Garman | 32 | 2025-12-15 | 2026-02-12 |
| A Study to Determine if the Drug, Pyrvinium Pamoate, is Safe and Tolerable in Patients With Pancreatic Cancer Pyrvinium Pamoate - Resectable Pancreatic Ductal Adenocarcinoma, Stage 0 Pancreatic Cancer AJCC v8 | Phase 1 | Active not recruiting | Thomas Jefferson University | 20 | 2021-07-29 | 2026-07-21 |
Pancreatic Neoplasms (1) · Stomach Neoplasms (1)
Katherine Garman (1) · National University Hospital, Singapore (1) · Thomas Jefferson University (1)
United States (2) · Singapore (1)
Harish Lavu, MD (1) · Katherine Garman, MD (1)